Skip to main content

Table 1 Summary of pncA polymorphisms of all 57 strains with interpretable PZA DST results

From: Pyrazinamide resistance-conferring mutations in pncA and the transmission of multidrug resistant TB in Georgia

Strain

Nucleotide

Substitution

DST+[Z]a

MTB lineageb

MLVA 15–9 type

Previously reported

Categoryc

12-14129

T14C

Ile5Thr

MDR+[R]

Haarlem

15898-15

No

−

12–17,889

A16C

Ile 6 Leu

MDR+[S]

Beijing K1

1065–32

Yes [10]

C

12–15893

T20C

Val7Ala

XDR+[R]

Beijing K1

1065–32

Yes [11, 37]

−

12–16359

T40C

Cys14Arg

MDR+[R]

Beijing V+/CHIN+

?-32

Yes [10, 11, 37, 46]

A

13–1786

G41A

Cys14Tyr

XDR+[R]

Beijing V+/CHIN+

100–32

Yes [37, 46]

−

12–16734

A146C

Asp49Ala

MDR+[R]

Beijing V+/CHIN+

100–32

Yes [10, 37, 46]

A

12–16077

A188C

Asp63Ala

MDR+[R]

Beijing V+/CHIN+

100–32

Yes [10, 37]

D

12–16119

G204 T

Trp68Cys

MDR+[R]

Haarlem

2943–31

Yes [10]

A

12–17593

C211T

His71Tyr

MDR+[R]

Beijing V+/CHIN+

100–32

Yes [10, 11, 37, 46]

A

12–14879

12–17704

12–19027

12–19131

A212C

His71Pro

MDR+[R]

Beijing K1

94–32

Yes [37]

−

13–774

A212G

His71Arg

MDR+[R]

Beijing V+/CHIN+

1047–32

Yes [10, 11, 37, 46]

A

12–15175

12–17995

12–18248

12–16269

A212G

His71Arg

M(X)DR+[R]

Beijing K1

94–32

See above

See above

12–13963

T254G

Leu85Arg

MDR+[R]

Beijing K1

407–32

Yes [10, 11, 37, 46]

A

12–14551

G356 T

Trp119Leu

MDR+[R]

Beijing K1

94–32

Yes [37]

−

12–17975

T389G

Val130Gly

MDR+[R]

Beijing V+/CHIN+

9375–32

Yes [10, 11, 37, 46]

A

12–16180

T412C

Cys138Arg

XDR+[R]

Beijing V+/CHIN+

100–32

Yes [10, 11, 37, 46]

A

12–17047

A422C

Gln141Pro

MDR+[R]

Beijing V+/CHIN+

100–135

Yes [10, 11, 37, 46]

A

12–18057

12–17993

12–16295

12–15251

12–18055

12–18893

12–19128

A422C

Gln141Pro

MDR+[R]

Beijing V+/CHIN+

100–32

See above

See above

12–17736

A422C

Gln141Pro

MDR+[R]

Beijing V+/CHIN+

9368–32

See above

See above

12–16850

A422C

Gln141Pro

MDR+[R]

Beijing V+/CHIN+

other

See above

See above

12–14180

C425T

Thr142Met

MDR+[R]

Beijing K1

94–32

Yes [10, 11, 37, 46]

A

12–18166

T448:G

Insertion → frameshift

MDR+[R]

Beijing V+/CHIN+

100–32

No

−

13–2219

wildtype

−

MDR+[S]

LAM

8013–52

−

−

12–17795

wildtype

−

mono-INH+[S]

LAM

843–52

−

−

12–16706

wildtype

−

pan-susceptible + [S]

Beijing K1

94–32

−

−

12–16496

12–15156

wildtype

−

mono-INH+[S]

Beijing V+/CHIN+

94–32

−

−

12–16505

wildtype

−

mono-INH+[S]

Beijing V+/CHIN+

407–32

−

−

12–17231

wildtype

−

MDR+[S]

Beijing V+/CHIN+

94–32

−

−

12–15460

wildtype

−

pan-susceptible + [S]

Beijing V+/CHIN+

94–32

−

−

13–56

wildtype

−

MDR-TB+[S]

Beijing V+/CHIN+

100–32

−

−

12–18360

wildtype

−

MDR-TB+[S]

Beijing V-

14852–32

−

−

12–19069

wildtype

−

MDR-TB+[S]

Euro-American

163–15

−

−

12–18493

wildtype

−

MDR-TB+[S]

Beijing K1

94–32

−

−

12–15155

wildtype

−

INHR+[S]

Euro-American

?-15

−

−

12–13700

wildtype

−

INHR+[S]

Haarlem

?-31

−

−

13–2072

wildtype

−

INHR+[S]

Euro-American

12411–15

−

−

13–421

wildtype

−

INHR+[S]

Haarlem

7361–31

−

−

12–18490

wildtype

−

INHR+[S]

Euro-American

768–26

−

−

13–172

wildtype

−

SR+[S]

Beijing V+/CHIN+

other

−

−

12–15239

wildtype

−

pan-susceptible + [S]

X

?-15

−

−

12–15737

wildtype

−

pan-susceptible + [S]

CAS

1059–25

−

−

12–16196

wildtype

−

pan-susceptible + [S]

Beijing SA−/CHIN-

785–32

−

−

12–18942

wildtype

−

pan-susceptible + [S]

Beijing K1

other

−

−

13–1

wildtype

−

pan-susceptible + [S]

Beijing V+/CHIN+

other

−

−

  1. a[Z] = PZA DST, [R] = resistant, [S] = susceptible; b M. tuberculosis lineage according to MLPA; c A = very high confidence resistance mutations, C = mutations with an unclear role, D = mutations not involved in phenotypic resistance according to [10]